ÂÜÀòÂÒÂ×

Christopher L Brummel is an experienced professional in the pharmaceutical industry, currently serving as Vice President of DMPK, Pharmacology, Biology, and Bioanalysis at Sun Pharmaceuticals since 2023. Prior to this role, Christopher held various leadership positions at Concert Pharmaceuticals, Inc. from 2015 to 2023, including Vice President of Nonclinical Research & Development and Director roles. Christopher’s career also includes a tenure at Celgene Avilomics Research as Head of Preclinical DMPK in 2014 and extensive experience at Vertex Pharmaceuticals from 1996 to 2013, where positions ranged from Scientist to Director. Christopher holds a Ph.D. in Physical Chemistry & Biophysical Chemistry from Cornell University and a BA in Chemistry & Biology from Earlham College.